Publications by authors named "T Deering"
Sotalol, a class III antiarrhythmic agent, is used to maintain sinus rhythm in patients with atrial fibrillation or atrial flutter (AFIB/AFL). Despite its efficacy, sotalol's use is limited by its potential to cause life-threatening ventricular arrhythmias due to QT interval prolongation. Traditionally, sotalol administration required hospitalization to monitor these risks.
View Article and Find Full Text PDFArticle Synopsis
- The field of electrophysiology (EP) has seen major innovations that help save lives and improve patient quality of life, but faces challenges like an aging population and costly, minimally beneficial therapies.
- To continue advancing EP, the community needs to explore how artificial intelligence (AI) can enhance healthcare delivery, research, and education while improving efficiency and patient outcomes.
- The white paper defines AI, discusses its potential to transform EP, and addresses requirements and ethical considerations for successful AI implementation in this field.